USPTO serial 97700280
CELL ONE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- DELGIZZI, RONALD ERNEST
- Law office
- TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with CELL ONE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
South San Francisco, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Bobby A. Ghajar
Bobby A. Ghajar COOLEY LLP1299 PENNSYLVANIA AVENUE, NW, SUITE 700WASHINGTON, DC 20004UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Bio processing and process development equipment for the manufacturing of therapeutics and biologics-based drug-delivery vehicles; Downloadable computer software for accessing a database featuring information in the medical field, specifically, cell therapy related information; Downloadable software applications for telephones, tablets, computers allowing the access to information and consulting in the field of health; Downloadable software applications for telephones, tablets, computers allowing the access to information, monitoring and management systems for the manufacture of advanced therapy and cell therapy medications; Downloadable databases in the field of manufacture of advanced therapy and cell therapy medications; Downloadable electronic publications in the nature of electronic questionnaires on the area of advanced therapy and cell therapy medications; Scientific and laboratory apparatus and instruments for the manufacturing of autologous and allogeneic biological cell therapies in the nature of laboratory centrifuges, cell sorting apparatus, bioreactors for laboratory use, and parts and fittings for all of the aforesaid goods; fully integrated laboratory apparatus and computer systems for use in autologous and allogenic cell therapy manufacturing, and parts and fittings therefor; Fully integrated laboratory apparatus and computer systems for use in autologous and allogenic cell therapy manufacturing, and parts and fittings therefor; Downloadable software for the manufacturing of autologous and allogeneic cell therapies; Downloadable software for automating the operations of biotechnological instruments used with manufacturing equipment for biological cell therapies; downloadable software for the execution, monitoring, analysis of cell therapy manufacturing workflows as well as process development workflows; downloadable software for the processing, separation, isolation, enrichment, depletion, cell activation, genetic modification, detection, screening, analysis and counting of material; downloadable software for generating electronic batch records for cell therapies | ACTIVE | — |
| 010 | Medical equipment for the manufacturing of autologous and allogeneic biological cell therapies for medical and non-veterinary purposes, namely, fully integrated system for use in the creation of biological cell therapies for medical purposes; disposable single-use containers for solutions used for the manufacturing of autologous and allogeneic biological cell therapies, namely, bags, pouches, cartridges, rigid and semi-rigid containers for concentrates and solutions in solid or liquid form for medical use; the foregoing excludes containers that are used to transport or ship temperature-sensitive goods, medicines, pharmaceuticals, and biologics in an insulated or temperature controlled manner | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 12, 2023 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 12, 2023 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 12, 2023 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 26, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 26, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 26, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 26, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 11, 2023 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Apr 11, 2023 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Dec 5, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 5, 2022 | NWAP | NEW APPLICATION ENTERED | — |